SPHDF OTC
Santhera Pharmaceuticals Holding AG
1W: -7.5%
1M: -21.3%
3M: -21.3%
YTD: +37.1%
1Y: +37.4%
3Y: +2591.2%
5Y: +115722.8%
$18.30
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$152M
+39.1% ▲
5Y CAGR: +5.8%
Total Liabilities
$125M
+151.2% ▲
5Y CAGR: +5.9%
Shareholders Equity
$28M
-53.8% ▼
5Y CAGR: +5.4%
Cash & Investments
$41M
+34.8% ▲
5Y CAGR: +5.5%
Total Debt
$41M
+91.1% ▲
5Y CAGR: -8.8%
Net Debt
$248K
+102.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $12M | $21M | $1M | $30M | $41M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $12M | $21M | $1M | $30M | $41M |
| Net Receivables | $2M | $2M | $1M | $440K | $14M |
| Inventory | $481K | $428K | $108K | $2M | $18M |
| Other Current Assets | $2M | $0 | $0 | $2M | $3M |
| Total Current Assets | $18M | $25M | $3M | $35M | $76M |
| Property, Plant & Equip. | $2M | $1M | $1M | $582K | $3M |
| Goodwill & Intangibles | $68M | $65M | $59M | $74M | $69M |
| Long-Term Investments | $552K | $468K | $444K | $424K | $245K |
| Other Non-Current Assets | $0 | $0 | $0 | $74M | $0 |
| Total Non-Current Assets | $71M | $66M | $61M | $75M | $77M |
| Total Assets | $89M | $91M | $64M | $110M | $152M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $2M | $4M | $4M | $9M |
| Short-Term Debt | $11M | $15M | $22M | $21M | $7M |
| Deferred Revenue | $1M | $13M | $0 | $0 | $56K |
| Other Current Liabilities | $12M | $2M | $12M | $10M | $29M |
| Total Current Liabilities | $29M | $33M | $49M | $44M | $46M |
| Long-Term Debt | $58M | $26M | $21M | $0 | $32M |
| Other Non-Current Liab. | $6M | $30M | $36M | $4M | $43M |
| Total Non-Current Liabilities | $66M | $57M | $58M | $5M | $79M |
| Total Liabilities | $95M | $90M | $107M | $50M | $125M |
| — Equity — | |||||
| Common Stock | $19M | $55M | $753K | $1M | $1M |
| Retained Earnings | -$501M | -$556M | -$628M | -$573M | -$615M |
| Accumulated OCI | -$3M | $508M | $2M | $0 | -$3M |
| Total Stockholders Equity | -$6M | $1M | -$44M | $60M | $28M |
| Total Liabilities & Equity | $89M | $91M | $64M | $110M | $152M |
| — Key Metrics — | |||||
| Total Debt | $71M | $43M | $44M | $22M | $41M |
| Net Debt | $59M | $22M | $43M | -$9M | $248K |
| Total Investments | $552K | $468K | $444K | $424K | $245K |